COMFORT: A Multicenter, Open-label, Randomized, Crossover Study
Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate pain the patient experienced following treatment of
varicose veins with Varithena® compared to radiofrequency ablation.
Phase:
Phase 4
Details
Lead Sponsor:
Boston Scientific Corporation BTG International Inc.